MD+DI writes about the Levita Magnetics® Series C funding announcement. The $26 million round will be used to support the regulatory and near-term commercial efforts for the Magnetic-Assisted Robotic Surgery (MARS™) platform. Levita also announced the appointment of Maria Sainz to Chairwoman of the board of directors. Read the full article here.
Series C financing to support regulatory process and initial market entry of the Levita® MARS™ platform designed to make robotic surgery accessible for all
System is Designed to Deliver Triple Impact: Clinical Benefit to Patients, Better Visualization and Control to Surgeons, and Higher Efficiency to Hospitals.
